Seattle Genetics | SGEN - Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
AbbVie USD 384.69B 19.14B 2026-03
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Amgen USD 189.89B 13.64B 2026-03
Astellas Pharma JPY 4.56T 770.92B 2026-03
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Celldex Therapeutics USD 1.81B 87M 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 11.75B 959M 2025-12
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 18.73B 660M 2026-03
Insmed USD 37.12B 6.68B 2025-12
Karyopharm Therapeutics USD 956M 821M 2026-05
MacroGenics USD 102M 4M 2025-12
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Novartis USD 307.76B 15.54B 2026-03
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Xencor USD 1.09B 256M 2025-12